NIH Grant Funds Treatment for Ultra-Rare CHCHD10-ALS Patients
March 18, 2025
$15 million grant supports the development of antisense oligonucleotide (ASO) therapeutics for ultra-rare genetic forms of ALS through the Silence ALS Initiative Lorem, a nonprofit